Roundup on trial: Law firms spent $91 million in one year to recruit plaintiffs for glyphosate-cancer suits

In 2019, an estimated $91 million was spent on ads seeking clients to pursue Roundup-related claims, making it the No. 1 product to be featured in TV advertising, according to X Ante, citing data from ad-tracking firm Kantar CMAG.

By contrast, only $23 million was spent on Roundup ads in 2020. Roundup ranked third for most-featured product, behind the heartburn drug Zantac and talcum powder, for which an estimated $37.9 million and $34.8 million were spent, respectively.

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

The decline in Roundup ad spending came as Bayer in June agreed to a $10.9 billion proposed settlement to resolve tens of thousands of lawsuits and claims alleging Roundup and its active ingredient glyphosate cause cancer. It denies the allegations.

Read the original post

Related article:  Hospitals face chronic shortages of injectable opioids. The COVID-19 pandemic made things worse.
Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend